Abstract:Background Porcine reproductive and respiratory syndrome virus (PRRSV) infection leads to substantial economic losses to the swine industry worldwide. However, no effective countermeasures exist to combat this virus infection so far. The most common antiviral strategy relies on directly inhibiting viral proteins. However, this strategy invariably leads to the emergence of drug resistance due to the error-prone nature of viral ploymerase. Targeting cellular proteins required for viral infection for developing new generation of antivirals is gaining concern. Recently, heat shock protein 90 (HSP90) was found to be an important host factor for the replication of multiple viruses and the inhibition of HSP90 showed significant antiviral effects. It is thought that the inhibition of HSP90 could be a promising broad-range antiviral approach. However, the effects of HSP90 inhibition on PRRSV infection have not been evaluated. In the current research, we tried to inhibit HSP90 and test whether the inhibition affect PRRSV infection. Methods We inhibit the function of HSP90 with two inhibitors, geldanamycin (GA) and 17- allylamono-demethoxygeldanamycin (17-AAG), and down-regulated the expression of endogenous HSP90 with specific small-interfering RNAs (siRNAs). Cell viability was measured with alamarBlue. The protein level of viral N was determined by western blotting and indirect immunofluorescence (IFA). Besides, IFA was employed to examine the level of viral double-stranded RNA (dsRNA). The viral RNA copy number and the level of IFN-β mRNA were determined by quantitative real-time PCR (qRT-PCR). Results Our results indicated that both HSP90 inhibitors showed strong anti-PRRSV activity. They could reduce viral production by preventing the viral RNA synthesis. These inhibitory effects were not due to the activation of innate interferon response. In addition, we observed that individual knockdown targeting HSP90α or HSP90β did not show dramatic inhibitory effect. Combined knockdown of these two isoforms was required to reduce viral infection. Conclusions Our results shed light on the possibility of developing potential therapeutics targeting HSP90 against PRRSV infection.

Hsp90 inhibitors directly block HSV-1 DNA replication via inducing degradation of pUL42

Hsp90 Inhibitors Prevent HSV-1 Replication by Directly Targeting UL42-Hsp90 Complex

Hsp90 inhibitor AT-533 blocks HSV-1 nuclear egress and assembly

Hsp90 Inhibitors Inhibit the Entry of Herpes Simplex Virus 1 into Neuron Cells by Regulating Cofilin-Mediated F-Actin Reorganization

AT-533, a Hsp90 Inhibitor, Attenuates HSV-1-induced Inflammation

Heat-Shock Protein 90 Promotes Nuclear Transport of Herpes Simplex Virus 1 Capsid Protein by Interacting with Acetylated Tubulin

Anti-herpes simplex virus efficacies of 2-aminobenzamide derivatives as novel HSP90 inhibitors.

P1.045 Zinc Ionophores Inhibit Herpes Simplex Virus Type 1 and 2 Replication Through Dysregulation of Ubiquitin-Proteasome Pathway

A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replication in vitro and in vivo

Silencing Herpes Simplex Virus Type 1 Capsid Protein Encoding Genes by Sirna: A Promising Antiviral Therapeutic Approach

Synthesis and in Vitro Anti-Hsv-1 Activity of a Novel Hsp90 Inhibitor BJ-B11.

Oleanolic Acid Derivative AXX-18 Exerts Antiviral Activity by Inhibiting the Expression of HSV-1 Viral Genes UL8 and UL52

Heat-shock Protein 90α is Involved in Maintaining the Stability of VP16 and VP16-mediated Transactivation of Α Genes from Herpes Simplex Virus-1

Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation

Inhibition of Herpes Simplex Virus Replication by a 2-Amino Thiazole Via Interactions with the Helicase Component of the UL5-UL8-UL52 Complex

Inhibition Activity of Herpes Virus (HSV) Replication by Α-Tif Sirna-Loaded PLGA-TPGS Nanoparticles in Vitro and in Vivo

Inhibition of HSP90 attenuates porcine reproductive and respiratory syndrome virus production in vitro

Adenovirus-mediated shRNA interference against HSV-1 replication in vitro

Antiviral Activity of PHA767491 Against Human Herpes Simplex Virus in Vitro and in Vivo

A Mutation in the DNA Polymerase Accessory Factor of Herpes Simplex Virus 1 Restores Viral DNA Replication in the Presence of Raltegravir

Grp94 Inhibitor HCP1 Suppressed the Replication of SVA in BHK-21 Cells and PK-15 Cells